Everett Harris & CO Novartis Ag Transaction History

Everett Harris & CO

  • $8 Billion
  • Q3 2024

A detailed history of Everett Harris & CO transactions in Novartis Ag stock. As of the latest transaction made, Everett Harris & CO holds 21,423 shares of NVS stock, worth $2.22 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,423
Previous 21,493 0.33%
Holding current value
$2.22 Million
Previous $2.29 Million 7.69%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$106.13 - $120.89 $7,429 - $8,462
-70 Reduced 0.33%
21,423 $2.46 Million
Q1 2024

Apr 19, 2024
SELL
$95.27 - $108.47 $56,209 - $63,997
-590 Reduced 2.67%
21,493 $2.08 Million
Q4 2023

Jan 18, 2024
SELL
$92.27 - $101.54 $593,849 - $653,511
-6,436 Reduced 22.57%
22,083 $2.23 Million
Q3 2023

Oct 23, 2023
SELL
$94.73 - $105.13 $132,622 - $147,182
-1,400 Reduced 4.68%
28,519 $2.9 Million
Q2 2023

Jul 26, 2023
SELL
$92.52 - $104.91 $129,528 - $146,874
-1,400 Reduced 4.47%
29,919 $3.02 Million
Q1 2023

Apr 24, 2023
SELL
$80.03 - $92.81 $76,028 - $88,169
-950 Reduced 2.94%
31,319 $2.88 Million
Q4 2022

Jan 20, 2023
SELL
$75.55 - $92.52 $1.5 Million - $1.84 Million
-19,870 Reduced 38.11%
32,269 $0
Q3 2022

Oct 21, 2022
SELL
$74.61 - $87.26 $946,278 - $1.11 Million
-12,683 Reduced 19.57%
52,139 $3.96 Million
Q2 2022

Jul 22, 2022
SELL
$80.52 - $93.75 $582,079 - $677,718
-7,229 Reduced 10.03%
64,822 $5.48 Million
Q1 2022

Apr 22, 2022
SELL
$80.11 - $90.62 $2.43 Million - $2.75 Million
-30,307 Reduced 29.61%
72,051 $6.32 Million
Q4 2021

Feb 02, 2022
SELL
$79.7 - $88.13 $10.4 Million - $11.5 Million
-130,665 Reduced 56.07%
102,358 $8.95 Million
Q3 2021

Nov 03, 2021
SELL
$81.78 - $95.14 $5.16 Million - $6 Million
-63,085 Reduced 21.3%
233,023 $19.1 Million
Q2 2021

Jul 29, 2021
BUY
$85.24 - $94.15 $337,720 - $373,022
3,962 Added 1.36%
296,108 $27 Million
Q1 2021

May 13, 2021
BUY
$83.5 - $98.47 $3.28 Million - $3.87 Million
39,316 Added 15.55%
292,146 $25 Million
Q4 2020

Feb 04, 2021
BUY
$78.07 - $94.43 $13.3 Million - $16.1 Million
170,286 Added 206.3%
252,830 $23.9 Million
Q3 2020

Nov 03, 2020
BUY
$82.14 - $91.0 $4.81 Million - $5.33 Million
58,523 Added 243.63%
82,544 $7.18 Million
Q2 2020

Jul 29, 2020
BUY
$80.93 - $91.1 $414,604 - $466,705
5,123 Added 27.11%
24,021 $2.1 Million
Q1 2020

Apr 29, 2020
BUY
$70.67 - $99.01 $78,797 - $110,396
1,115 Added 6.27%
18,898 $1.56 Million
Q4 2019

Jan 27, 2020
SELL
$84.35 - $95.37 $193,330 - $218,588
-2,292 Reduced 11.42%
17,783 $1.68 Million
Q3 2019

Nov 06, 2019
SELL
$85.54 - $94.26 $1,710 - $1,885
-20 Reduced 0.1%
20,075 $1.75 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $23,600 - $29,046
-313 Reduced 1.53%
20,095 $1.84 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $15,063 - $17,230
-200 Reduced 0.97%
20,408 $1.96 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $40,144 - $44,700
-545 Reduced 2.58%
20,608 $1.77 Million
Q2 2018

Jul 27, 2018
SELL
$64.91 - $73.36 $11,099 - $12,544
-171 Reduced 0.8%
21,153 $1.6 Million
Q1 2018

Apr 20, 2018
SELL
$70.39 - $84.15 $21,117 - $25,245
-300 Reduced 1.39%
21,324 $1.72 Million
Q4 2017

Feb 01, 2018
SELL
$72.33 - $77.64 $45,857 - $49,223
-634 Reduced 2.85%
21,624 $1.82 Million
Q3 2017

Oct 11, 2017
BUY
$74.14 - $77.27 $1.65 Million - $1.72 Million
22,258
22,258 $1.91 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email